Skip to Content

Health

East Coasters just felt tremors. What to do if you have earthquake anxiety, according to an expert

By Sandee LaMotte, CNN (CNN) — Homes and buildings across the Northeast shook briefly Friday morning as a 4.8 magnitude earthquake hit near New York City, startling residents as far away as Philadelphia and Washington, DC. No life-threatening situations or reports of significant damage have been reported so far, authorities said, but investigations are ongoing.

Continue Reading

First-degree relatives are 9 times more likely to develop a serious form of depression, study says

By Sandee LaMotte, CNN (CNN) — Close relatives of people with treatment-resistant depression are nine times more likely to develop depression that also does not respond to traditional treatment, a new study found. For people with treatment-resistant depression, also known as TRD, standard treatments such as psychiatric therapy and antidepressants may not work well, if at

Continue Reading

First living patient with transplanted pig kidney goes home from the hospital

By John Bonifield, Brenda Goodman and Carma Hassan, CNN (CNN) — Rick Slayman, the world’s first living recipient of a genetically edited pig kidney transplant, was discharged from the hospital Wednesday, two weeks after his operation, Massachusetts General Hospital said in a statement. “He is recovering well and will continue to recuperate at home with his family,”

Continue Reading

First living patient with transplanted pig kidney goes home from the hospital

WCVB, MASS GENERAL HOSPITAL, CNN By John Bonifield, Brenda Goodman and Carma Hassan, CNN (CNN) — Rick Slayman, the world’s first living recipient of a genetically edited pig kidney transplant, was discharged from the hospital Wednesday, two weeks after his operation, Massachusetts General Hospital said in a statement. “He is recovering well and will continue to recuperate

Continue Reading

FDA clears first digital treatment for depression, but experts caution that research is still early

By Mira Cheng, CNN (CNN) — The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder. Rejoyn, made by Otsuka Pharmaceutical and Click Therapeutics, is a smartphone app intended for use alongside antidepressant medications for people 22 and older who have a diagnosis of

Continue Reading
Skip to content